key: cord-0891066-drc8grqp
authors: Zhan, Wuqiang; Tian, Xiaolong; Zhang, Xiang; Xing, Shenghui; Song, Wenping; Liu, Qianying; Hao, Aihua; Hu, Yuxia; Zhang, Meng; Chen, Zhenguo; Ying, Tianlei; Lan, Fei; Sun, Lei
title: A potent SARS-CoV-2 antibody neutralizes Omicron variant by disassembling the spike trimer
date: 2022-03-22
journal: bioRxiv
DOI: 10.1101/2022.03.21.485243
sha: 76e1e90d990ce0b9a75ed42accc27b505bc5c156
doc_id: 891066
cord_uid: drc8grqp

The continuous emergence of novel SARS-CoV-2 variants poses new challenges to the fight against the COVID-19 pandemic. The newly emerging Omicron strain caused serious immune escape and raised unprecedented concern all over the world. The development of antibody targeting conserved and universal epitope is urgently needed. A subset neutralizing antibody(nAbs) against COVID-19 from convalescent patients were isolated in our previous study. Here in this study, we investigated the accommodation of these nAbs to SARS-CoV-2 variants of concerns (VOCs), revealing that IgG 553-49 neutralizes pseudovirus of SARS-CoV-2 Omicron variant. In addition, we determined the cryo-EM structure of SARS-CoV-2 spike complexed with three antibodies targeting different epitopes, including 553-49, 553-15 and 553-60. Notably, 553-49 targets a novel conserved epitope and neutralizes virus by disassembling spike trimers. 553-15, an antibody that neutralizes all the other VOCs except omicron, cross-links two spike trimers to form trimer dimer, demonstrating that 553-15 neutralizes virus by steric hindrance and virion aggregation. These findings suggest the potential to develop 49 and other antibody targeting this highly conserved epitope as promising cocktail therapeutics reagent for COVID-19. Importance The newly emergence of Omicron strain caused higher immune escape, raising unprecedented concerns about the effectiveness of antibody therapies and vaccines. In this study, we identified a SARS-CoV-2 Omicron neutralizing antibody 553-49, which neutralizes Omicron variant by targeting a completely conserved novel epitope. Besides, we revealed that IgG 553-15 neutralizes SARS-CoV-2 by crosslinking virions and 553-60 functions by blocking receptor binding. Comparison of different RBD epitopes revealed that the epitope of 553-49 is hidden in the S trimer and keeps high conservation during SARS-CoV-2 evolution, making 553-49 a promising therapeutics reagent to fight against the emerging Omicron and future variant of SARS-CoV-2.

and various neutralization mechanisms might be an effective way to fight against the 79 SARS-CoV-2 variants. Our previous study identified a set of antibodies from 80 convalescent patients targeting four different epitopes of S, including four RBD-81 targeting IgGs: 553-15 (abbrev. 15 ), 553-60 (abbrev. 60), 553-63(abbrev. 63), 553-82 49(abbrev. 49) and one non-RBD IgG, 413-2(14) . Here in this study, we investigated 83 the neutralization activity of these nAbs to SARS-CoV-2 COVs. Binding assay and Broadly neutralizing activity of IgG 49 97 We first used BLI to investigate the affinity between spike protein of different 98 SARS-CoV-2 variants (WT, Alpha, Beta, Gamma, Delta, Omicron) and five IgGs: 15, 99 60, 63, 49, and 413-2, to determine whether these monoclonal antibodies accommodate 100 the emerged variants. The Alpha S could bind to all five antibodies, while the Beta and 101 Gamma S proteins were not able to bind with 60, 63 (Fig. S1 ). IgG 15 retained high 102 binding ability to S of Alpha, Beta, Gamma, Delta at 4. 05, 4.25, 9.34 and 2.78nM, 103 respectively, but could not bind Omicron S (Fig. S1 ). Fortunately, 49 maintained the 104 binding affinity to S of all five VOCs at 0. 23, 25.51, 6.99, 7.19 and 15.21 nM, 105 respectively ( Fig. 1 and Fig. S1 ). 106 We next assayed the neutralizing activity of these five antibodies against SARS-107 CoV-2 variants and SARS-CoV pseudoviruses. They neutralized WT SARS-CoV-2 108 pseudoviruses with 50% inhibition concentration (IC50) values as 2.94, 0.79, 10.82, 0.11, 109 13.91µg/mL (Fig. S1 ), respectively. The neutralization activities of 60 and 63 on CoV-2 Beta and Gamma strains were completely abolished, which is consistent with 111 the result of BLI (Fig. S1 ). The Delta strain evades the neutralization activity mediated 112 by these antibodies, like 60, 49, 63, 413-2, although the spike protein binds tightly to 113 these antibodies (Fig. S1) To understand the broad neutralization mechanism of 49, we used Cryo-EM to 123 determine the structure of 49 complexed with prefusion stabilized ectodomain of 124 SARS-CoV2 Omicron S. The purified omicron S trimer was mixed with 49 at 1:1.5 125 molar ratio, incubated at 4 ℃ for 2 hour and further purified by gel filtration. The peak 126 fraction of gel-filtration was used for cryo-EM data collection. Two states of particles 127 were observed: Omicron S trimer at apo state (Apo-OS) and S monomer complexed 128 with 49 (OS-49) (Fig.S2 , S3, S4). Thus, the Omicron S trimers were disassembled into 129 monomers upon 49 binding. The cryo-EM structure of Omicron S trimer was 1 pair hydrophobic interaction.

Totally 35 residues of RBD are involved in the interaction and they are completely 140 conserved among all VOCs (Fig.2D, 6 ), revealing an extremely conservative epitope.

In S trimer, this epitope is covered by the NTD of the neighboring protomer no matter 142 the RBD adopts up or down conformation (Fig.2C ). Both structural alignment of the Although 15 targets the non-RBM region, the previous study showed that 15 was 194 able to compete with ACE2 for binding with membrane-bound S protein(14). 

The epitope of 60-up is near the RBM region and overlaps with residues G485, 213 Q493 and Y449, which are involved in ACE2 binding (Fig .5E ). In contrast to 15, 60 214 Fab molecule has a smaller footprint, with heavy and light chains burying 557 Å 2 and 215 101 Å 2 surface area, respectively. The interaction between 60 Fab and RBD is primarily 216 driven by CDRH1, CDRH2, CDRH3 and CDRL1 through hydrophilic and hydrophobic 217 interaction (Fig. 5D ). The residues G482, E484, Y449, N481 of RBD were involved 218 into the hydrophilic interaction by forming one salt bridge and 7 hydrogen bonds.

Hydrophobic contacts formed between V483, F490, L452, Y449 from RBD and Y92, 220 W106, L55, L54, I30 of 60 further enhanced the interaction (Fig. 5D) .

In addition, the binding of 60 to the down RBD introduced additional contacts 222 through interaction with the neighboring up RBD (Fig.5B, 5C ). The additional contact 223 is primarily due to intensive hydrophilic interaction. Salt bridges and hydrogen bonds 224 are formed between Q1, T57 and D61 from VH and VL and R408, D405, N437, Y508, 

The epitope of 60 partly overlaps with RBM, which is easily exposed on the surface of Cryo-EM image processing 379 All the data processing was carried out using either modules on, or through, RELION 380 v3.0 and cryoSPARC(28).

For S-15 complex (Fig.S10) , a total of 6,943 movie stacks was binned 2 × 2, dose 382 weighted, and motion corrected using MotionCor2(29). Parameters of contrast transfer 383 function (CTF) were estimated by using Gctf(30). All micrographs then were manually 384 selected for further particle picking upon ice condition, defocus range and estimated 385 resolution. Particles were initially auto-picked by using the Laplacian-of-Gaussian 386 method and then subjected into two-dimensional (2D) classification. The top-class 387 averages were used as the 2D reference for template-picking, yielding 403,685 particles.

Binned 4 × 4 particles (4.28 Å/pixel) were extracted and subjected to a routine process 389 of 2D classification, 3D initial model, 3D classification and 3D auto-refine followed by 390 subsequent re-centering and re-extraction binned 1 × 1 (1.07 Å/pixel). Finally, 188,942 391 particles were grouped and subjected to auto refinement and postprocessing, yielding a 392 trimer dimer density map at 4.47-Å overall resolution with C1 symmetry.

To get a higher-resolution asymmetric single-trimer map, particles were subjected of NRAbs were fitted into map of trimer and merged with it using "vop maximum" 408 command in UCSF Chimera. The composite map for S-15 asymmetric trimer dimer 409 was also formed by using "vop maximum" with 2 × NRAbs maps and 2 × trimer maps, 410 which were all fitted in original 4.47-Å trimer dimer map.

For S-60 (Fig.S13) , a total of 3515 movie stacks was motion-corrected and CTF-412 estimated. 3450 among these micrographs were selected for further processing. After Chimera.

For Apo S (D614G) (Fig.S6) , routine procedure was carried out. At last, 2,001.157 436 particles yielded a 2.70 -Å map of apo spike.

For Omicron S-49 (Fig.S4) , 7,294 movies were motion-corrected and CTF-438 estimated. Among these, 5,896 were selected for further processing. After blob-picking 439 in cryoSPARC and 2D classification, trimer and monomer particles were observed. 

A new coronavirus 506 associated with human respiratory disease in China

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Projecting the transmission 512 dynamics of SARS-CoV-2 through the postpandemic period

Structure, Function, and 514 Antigenicity of the SARS-CoV-2 Spike Glycoprotein

SARS-CoV-2 Cell Entry 517

Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

A humanized neutralizing antibody against MERS-CoV targeting the 524 receptor-binding domain of the spike protein

Cryo-electron microscopy structures of 528 the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

Proteolytic activation of SARS-CoV-2 spike protein

Omicron escapes the majority of existing SARS-CoV-2 538 neutralizing antibodies

Occupancy and mechanism in antibody-mediated neutralization 540 of animal viruses

Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection

Enhanced fusogenicity and pathogenicity of SARS-CoV-2

Delta P681R mutation

Broad 554 neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody

Defining variant-resistant epitopes targeted by SARS-557

CoV-2 antibodies_ A global consortium study

EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch

Mediate Endosomal Positioning of Receptor-Binding Domains

Structural basis for 566 neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody

Structural basis for the 573 neutralization of SARS-CoV-2 by an antibody from a convalescent patient

An ultrapotent pan-beta-coronavirus lineage B (beta-CoV-B) 578

neutralizing antibody locks the receptor-binding domain in closed conformation by targeting 579 its conserved epitope

Occupancy and mechanism in antibody-mediated neutralization 581 of animal viruses

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

A highly conserved cryptic 588 epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV

Antibody to a Functionally Conserved Site Is Mediated by Avidity

Structure-596 based design of prefusion-stabilized SARS-CoV-2 spikes

Automated electron microscope tomography using robust prediction 598 of specimen movements

cryoSPARC: algorithms for rapid 600 unsupervised cryo-EM structure determination

MotionCor2: anisotropic 602 correction of beam-induced motion for improved cryo-electron microscopy

Insulin resistance and diabetes caused by genetic or diet-induced KBTBD2 deficiency 606 in mice

Chimera--a visualization system for exploratory research and analysis

New 611 tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife 7

Features and development of Coot

Real-615 space refinement in PHENIX for cryo-EM and crystallography

ChimeraX: Structure visualization for researchers, educators, and developers

FIG 1 Accommodation of monoclonal antibodies to SARS-CoV-2 Omicron variant. (A) 623 BLI sensorgrams and kinetics of monoclonal antibodies binding to SARS

Omicron spike protein. (B) Neutralizing activity of IgG (15

SARS-CoV-2 WT and Omicron pseudoviruses (PSV)

The 629 RBD is displayed in yellow surface. The heavy chain and light chain of 49 are shown 630 as cartoon colored in blue and cyan, respectively. (B) The interaction of 49-VH(left) 631 and 49-VL(right) with Omicron RBD. (C) The apo Omicron S model displayed in side 632 and top view. The 49 epitope (colored in blue) on Omicron RBD was covered by the 633 NTD of adjacent protomer. (D) Close-up view of 49 epitope. The residues involved in 634 the interaction were labeled. (E-F) Binding of 49 to one RBD-up spike trimer (E) or a 635 wide open RBD (PDB: 7WHK) (F) would clash

Side and top view of the trimer of spike trimer binding 640 three 15 fabs. (B) The model of apo S D614G trimer displayed in ribbon (C) IgG 15 641 induced all RBDs to open state. Comparison of 15 bound S protomers with apo-up S 642 protomer (medium and right)

A) Close-up-view of two opposite RBD 645 region. (B) VH of 15 binds the RBD through the hydrophobic and hydrophilic 646 interaction between CDRH3 loop and RBD (369-384) (left); VL of 15 binds the RBD 647 through the CDRL1 and CRL2 loop (medium); The interaction between VH

Omicron RBD was destroyed by the mutation of S373P

Side and top view of the trimer with three 60 fabs in surface 653 representation. (B) Superimposition of up RBD with RBD-ACE2 (PDB:6LZG) 654 revealed a minor clash between the ACE2 and 60. (C) The interaction between -60-1 655 and neighboring open RBD. (D)The interface of 60-spike; VH of 60-1 binds the closed 656 RBD through the CDRH1, CDRH2 and CDRH3 loop (left); (C) VL of 60-1 binds the 657 closed RBD

Surface representation of RBD and buried binding site, including 60 (Orange), 60 659 additional contact (brown), ACE2 (cyan) and 60 epitope overlaps with RBM region

FIG 6 Epitope and neutralization mechanism of three nAbs. (A) Comparison of 49, 15, 663 60 epitopes on S RBD. S RBD is displayed in green surface. The 49, 15 and 60 epitopes 664 are colored blue, magenta and orange, respectively. (B) Sequence alignment of SARS-665

CoV-2 WT and all VOCs, showing that IgG 49 targets to a completely conserved 666 epitope. Conserved amino acids are highlighted as red. Residues involved in 49, 15, 60 667 interactions are marked with triangle in blue

Residues involved in both 49 and 60 binding are marked with triangle in red

Schematic model of the neutralization mechanisms of 49, 15 and 60

FIG S1 Accommodation of monoclonal antibodies to SARS-CoV-2 VOCs

sensorgrams and kinetics of monoclonal antibodies binding to spike protein of SARS-675

CoV-2 Variants. 15(A) 60(B) 49(C) 63(D) 413-2(E). (F) Neutralizing activity of IgG 676 against SARS-CoV-2, SARS-CoV-2 variants

CoV pseudoviruses (PSV)

FIG S2 49 binds Omicron S trimer and disassembles it. (A) Purification of 49-Omicron 680 S complex. The gel-filtration curved showed that 49 and S protein can form complex

Negative stain images of 49-Omicron S complex, showing that incubating with 49 682 for 2h leads to Omicron S trimer disassembling. (C) The 2D classification result of 683 cryo-EM data collected using 1.5h incubation complex, the spike trimer (left) and the 684 spike protomer with

FIG S3 Cryo-EM data collection and processing of SARS-CoV-2 Omicron protomer 687 in complex with 49. (A) Representative electron micrograph of 49 bound SARS-CoV-688

B) 2D classification results of 49 bound SARS-CoV-2 Omicron Spike protein

The reconstruction map of SARS-CoV-2 Omicron Spike trimer and its gold-standard 690 FSC curve from cryoSPARC. (D) The reconstruction map of 49 bound SARS

Omicron Spike protomer and its gold-standard FSC curve from cryoSPARC

FIG S4 Data processing flowchart of 49 bound SARS-CoV-2 Omicron S protein

FIG S5 Cryo-EM data collection and processing of S D614G. (A) Representative 695 electron micrograph of SARS-CoV-2 S. (B) 2D classification results of SARS

C) The reconstruction map of SARS-CoV-2 S. (D) Gold-standard Fourier shell 697 correlation curves for each structure

FIG S6 Data processing flowchart of SARS-CoV-2 apo S trimer

A-D) Purification and Negative stain images of 15-S (WT, Beta, Delta) 703 complex. The Negative stain image shows that binding of 15 induced Spike trimer 704 forming trimer dimer. (E) Purification and Negative stain images of

A) Representative 709 electron micrograph of 15 bound SARS-CoV-2 S (B) 2D classification results of 15 710 bound SARS-CoV-2 S. (C) The reconstruction map of trimer dimer, trimer, and three 711 local refinement maps. (D) Gold-standard Fourier shell correlation curves for each 712 structure

FIG S9 Data processing flowchart of 15 bound SARS-CoV-2 S D614G trimer

FIG S10 Fc domains of 15-IgGs indicated in cryo-EM data. Fc domain is clear when

FIG S11 Comparison of 15, ACE2, CR3022, EY6A and their epitopes on the RBDs of

A) Surface representation of RBD and buried binding site

Orchid indicates ACE2 epitope, salmon VH, light gray VL, purple VH and VL, 722 respectively. (B) Comparison of Fab 15, EY6A, CR3022 and ACE2 upon binding to 723 SARS-CoV-2 RBD and 15 would clash with ACE2. (C) The RBD side view of Fab

EY6A, CR3022 upon binding to SARS-CoV-2 RBD

FIG S12 Cryo-EM data collection and processing of 60-S D614G complex

Representative electron micrograph of 60 bound SARS-CoV-2 S. (B) 2D classification 728 results of 60 bound SARS-CoV-2 S. (C) The reconstruction map of 60 bound SARS

CoV-2 S at two states and three locally refined maps. (D) Gold-standard Fourier shell 730 correlation curves for each structure. The 0.143 cut-off is indicated by a horizontal 731 dashed line

 475 We thank Center of Cryo-Electron Microscopy, Fudan University and Center for 476 Biological Imaging of Institute of Biophysics (IBP) for the supports on cryo-EM data